Surgery for Borderline Resectable Pancreatic Ductal Adenocarcinoma Preoperative Planning, Technical Considerations, and Building a Program

被引:0
|
作者
Drake, Justin [1 ]
Anaya, Daniel A. [1 ,2 ]
Fleming, Jason B. [1 ,3 ]
Denbo, Jason W. [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA
[2] UT Southwestern Med Ctr, Div GI Surg, Dallas, TX USA
[3] UT Southwestern Med Ctr, Dept Surg, Dallas, TX USA
关键词
Ancreaticoduodenectomy; Periampullary region; Oncologic therapy; Pancreatic surgery; CONSENSUS STATEMENT; CANCER; PANCREATICODUODENECTOMY; CARCINOMA; AMPULLA;
D O I
10.1016/j.suc.2024.07.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:1031 / 1048
页数:18
相关论文
共 50 条
  • [21] The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma
    Tatsuma Sakaguchi
    Sohei Satoi
    Tomohisa Yamamoto
    So Yamaki
    Mitsugu Sekimoto
    Surgery Today, 2020, 50 : 335 - 343
  • [22] Optimal Treatment for Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma A Multicenter Retrospective Study
    Satoi, Sohei
    Yamamoto, Tomohisa
    Uchida, Kazushige
    Fujii, Tsutomu
    Kin, Toshifumi
    Hirano, Satoshi
    Hanada, Keiji
    Itoi, Takao
    Murakami, Yoshiaki
    Igarashi, Hisato
    Eguchi, Hidetoshi
    Kuroki, Tamotsu
    Shimizu, Yasuhiro
    Tani, Masaji
    Tanno, Satoshi
    Tsuji, Yoshihisa
    Hirooka, Yoshiki
    Masamune, Atsushi
    Shimokawa, Toshio
    Yamaue, Hiroki
    Okazaki, Kazuichi
    PANCREAS, 2020, 49 (06) : 837 - 844
  • [23] Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma? Reply
    Suurmeijer, J. Annelie
    Besselink, Marc G.
    van Laarhoven, Hanneke W. M.
    JAMA ONCOLOGY, 2022, 8 (12) : 1851 - 1852
  • [24] Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma
    Shuai Xu
    Xiu-Ping Zhang
    Guo-Dong Zhao
    Wen-Bo Zou
    Zhi-Ming Zhao
    Qu Liu
    Ming-Gen Hu
    Rong Liu
    Hepatobiliary & Pancreatic Diseases International, 2023, 22 (02) : 160 - 168
  • [25] Efficacy of neoadjuvant chemoradiotherapy followed by pancreatic resection for older patients with resectable and borderline resectable pancreatic ductal adenocarcinoma
    Suto, Hironobu
    Oshima, Minoru
    Ando, Yasuhisa
    Matsukawa, Hiroyuki
    Takahashi, Shigeo
    Shibata, Toru
    Kamada, Hideki
    Kobara, Hideki
    Masaki, Tsutomu
    Kumamoto, Kensuke
    Suzuki, Yasuyuki
    Okano, Keiichi
    HPB, 2023, 25 (01) : 136 - 145
  • [26] Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma
    Xu, Shuai
    Zhang, Xiu-Ping
    Zhao, Guo-Dong
    Zou, Wen-Bo
    Zhao, Zhi-Ming
    Liu, Qu
    Hu, Ming-Gen
    Liu, Rong
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (02) : 160 - 168
  • [27] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Homma, Yuki
    Taniguchi, Koichi
    Murakami, Takashi
    Nakagawa, Kazuya
    Nakazawa, Masatoshi
    Matsuyama, Ryusei
    Mori, Ryutaro
    Takeda, Kazuhisa
    Ueda, Michio
    Ichikawa, Yasushi
    Tanaka, Kuniya
    Endo, Itaru
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) : 670 - 676
  • [28] Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
    Maggino, Laura
    Malleo, Giuseppe
    Marchegiani, Giovanni
    Viviani, Elena
    Nessi, Chiara
    Ciprani, Debora
    Esposito, Alessandro
    Landoni, Luca
    Casetti, Luca
    Tuveri, Massimiliano
    Paiella, Salvatore
    Casciani, Fabio
    Sereni, Elisabetta
    Binco, Alessandra
    Bonamini, Deborah
    Secchettin, Erica
    Auriemma, Alessandra
    Merz, Valeria
    Simionato, Francesca
    Zecchetto, Camilla
    D'Onofrio, Mirko
    Melisi, Davide
    Bassi, Claudio
    Salvia, Roberto
    JAMA SURGERY, 2019, 154 (10) : 932 - 942
  • [29] International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
    Isaji, Shuji
    Mizuno, Shugo
    Windsor, John A.
    Bassi, Claudio
    Fernandez-del Castillo, Carlos
    Hackert, Thilo
    Hayasaki, Aoi
    Katz, Matthew H. G.
    Kim, Sun-Whe
    Kishiwada, Masashi
    Kitagawa, Hirohisa
    Michalski, Christoph W.
    Wolfgang, Christopher L.
    PANCREATOLOGY, 2018, 18 (01) : 2 - 11
  • [30] Immunological Impact of Neoadjuvant Chemoradiotherapy in Patients with Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Yuki Homma
    Koichi Taniguchi
    Takashi Murakami
    Kazuya Nakagawa
    Masatoshi Nakazawa
    Ryusei Matsuyama
    Ryutaro Mori
    Kazuhisa Takeda
    Michio Ueda
    Yasushi Ichikawa
    Kuniya Tanaka
    Itaru Endo
    Annals of Surgical Oncology, 2014, 21 : 670 - 676